CA2763092A1 - Use of a composition for the treatment of mucositis - Google Patents

Use of a composition for the treatment of mucositis Download PDF

Info

Publication number
CA2763092A1
CA2763092A1 CA2763092A CA2763092A CA2763092A1 CA 2763092 A1 CA2763092 A1 CA 2763092A1 CA 2763092 A CA2763092 A CA 2763092A CA 2763092 A CA2763092 A CA 2763092A CA 2763092 A1 CA2763092 A1 CA 2763092A1
Authority
CA
Canada
Prior art keywords
composition
mucositis
chitosan
range
negatively charged
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2763092A
Other languages
English (en)
French (fr)
Inventor
Lars Adolfsson
Olle Larm
Anders Westermark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EXTHERA AB
Original Assignee
EXTHERA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EXTHERA AB filed Critical EXTHERA AB
Publication of CA2763092A1 publication Critical patent/CA2763092A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA2763092A 2009-06-10 2010-06-10 Use of a composition for the treatment of mucositis Abandoned CA2763092A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0950441-6 2009-06-10
SE0950441 2009-06-10
PCT/SE2010/050650 WO2010144044A1 (en) 2009-06-10 2010-06-10 Use of a composition for the treatment of mucositis

Publications (1)

Publication Number Publication Date
CA2763092A1 true CA2763092A1 (en) 2010-12-16

Family

ID=43309105

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2763092A Abandoned CA2763092A1 (en) 2009-06-10 2010-06-10 Use of a composition for the treatment of mucositis

Country Status (9)

Country Link
US (1) US8906883B2 (enExample)
EP (1) EP2440216A4 (enExample)
JP (1) JP2012529506A (enExample)
CN (1) CN102458419A (enExample)
AU (1) AU2010259284A1 (enExample)
BR (1) BRPI1009741A2 (enExample)
CA (1) CA2763092A1 (enExample)
RU (1) RU2011152518A (enExample)
WO (1) WO2010144044A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022393B2 (en) 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
US11717532B2 (en) 2010-04-06 2023-08-08 Synedgen, Inc. Methods and compositions for treating wounds utilizing chitosan compounds

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015022907A1 (ja) * 2013-08-13 2015-02-19 生化学工業株式会社 カチオン化キトサンを含有する医薬
EP3060243A4 (en) * 2013-10-22 2017-03-29 Cantex Pharmaceuticals, Inc. Methods of treating and preventing radiation damage
US20180228832A1 (en) * 2015-08-18 2018-08-16 Pharma Seeds Create, Llc Stomatological composition containing nsaid or heparin compound
EP3787593A1 (en) * 2018-05-04 2021-03-10 Bonoss Medical Aktiebolag A composition for reduction of scar formation
WO2019236453A1 (en) 2018-06-03 2019-12-12 Glycomira Therapeutics, Inc. Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and /or chemotherapy
US20230181624A1 (en) * 2020-04-24 2023-06-15 Intact Therapeutics, Inc. Compositions and methods for treatment of gastrointestinal bleeding
EP3981505B1 (en) * 2020-10-12 2024-11-27 Gambro Lundia AB Membrane with immobilized anticoagulant and process for producing same
EP4401784A4 (en) * 2021-09-17 2025-09-10 Shawn Walker USE OF CHITOSAN COMPLEXES OR COMPOSITIONS TO REDUCE THE INFILTRATION OF ENVIRONMENTAL FACTORS INTO THE BRAIN

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402529D0 (sv) * 1994-07-19 1994-07-19 Astra Ab Anti-adherensmedel
SE9402531L (sv) * 1994-07-19 1996-01-20 Medicarb Ab Sårläkningsmedel
SE507028C2 (sv) 1996-08-06 1998-03-16 Medicarb Ab Ny medicinsk användning
US6989156B2 (en) * 2001-04-23 2006-01-24 Nucryst Pharmaceuticals Corp. Therapeutic treatments using the direct application of antimicrobial metal compositions
US7547433B2 (en) * 2001-02-15 2009-06-16 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
EP1539192A1 (en) 2002-04-24 2005-06-15 Medicarb AB Composition and kit for the treatment of inflammatory bowel diseases
JP2006508075A (ja) * 2002-10-07 2006-03-09 オラファーマ， インコーポレイテッド 粘膜付着性テトラサイクリン製剤
AU2005285040A1 (en) * 2004-09-14 2006-03-23 Molecular Therapeutics, Inc. D-methionine formulation with improved biopharmaceutical properties
US20080118542A1 (en) 2005-01-19 2008-05-22 Bonoss Medical Ab Growth Factor Composition
DE102006024831B4 (de) 2006-05-24 2008-03-27 Heraeus Quarzglas Gmbh & Co. Kg Verfahren zur Herstellung eines Halbzeugs aus synthetischem Quarzglas
US20080299050A1 (en) 2006-10-05 2008-12-04 Drugtech Corporation Topical therapies for oral mucositis and other conditions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11717532B2 (en) 2010-04-06 2023-08-08 Synedgen, Inc. Methods and compositions for treating wounds utilizing chitosan compounds
US10022393B2 (en) 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
US10716803B2 (en) 2012-09-20 2020-07-21 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock

Also Published As

Publication number Publication date
BRPI1009741A2 (pt) 2016-03-15
CN102458419A (zh) 2012-05-16
WO2010144044A1 (en) 2010-12-16
AU2010259284A1 (en) 2011-12-15
RU2011152518A (ru) 2013-07-20
JP2012529506A (ja) 2012-11-22
EP2440216A4 (en) 2013-09-11
US8906883B2 (en) 2014-12-09
EP2440216A1 (en) 2012-04-18
US20120077773A1 (en) 2012-03-29

Similar Documents

Publication Publication Date Title
US8906883B2 (en) Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate
JP4194653B2 (ja) アフタ口内潰瘍に伴う痛みの即効的解放のための薬剤組成物
KR100761051B1 (ko) 점막염, 구내염 및 베체트 증후군 치료용 약학적 조성물
US6828308B2 (en) Compositions and methods for the treatment or prevention of inflammation
JPH0739347B2 (ja) 硫酸化糖類の用途
HU220758B1 (hu) Eljárás hialuronsavat és nem szteroid gyulladásgátlót tartalmazó, rák kezelésére alkalmas gyógyászati készítmények előállítására
WO2002085402A1 (en) Methods and compositions for treating oral and eosophageal lesions
US5972906A (en) Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
US20060189526A1 (en) Compositions containing an intestinal trefoil peptide and a mucoadhesive
CA2152398A1 (en) Hyaluronic acid-urea pharmaceutical compositions and uses
EP0988040A1 (en) Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain
HU228669B1 (en) Pharmaceutical compositions for the treatment of painful, inflammatory and ulcerative conditions of moist epithelial surfaces such as mucositis, stomatitis and behcet's syndrome
JP4685242B2 (ja) ヒアルロン酸を用いた放射線膀胱炎の予防、軽減、および治療法
JP6595717B2 (ja) 骨関節炎治療のための親水化されたスルファサラジンおよびヒアルロン酸を含む組成物およびその製造方法
CA2434608C (fr) Favorisation de la reconstruction cellulaire et/ou de la differenciation cellulaire avec sucre non metabolisable et un absorbant polymerique
US10172975B2 (en) Gel-forming agent comprising sulfa agent and chitosan agent and having powdered dosage form
RU2258516C1 (ru) Способ лечения красного плоского лишая
WO2015023226A1 (en) Use of a composition comprising chitosan and a negatively charge polysaccharide for the treament of salivary dysfuntion
EP2908911A1 (en) Compositions comprising a silver salt of sucrose octasulfate and a potassium salt of sucrose octasulfate for protection of mucosal epithelia
Farrer Pharyngitis and tonsillitis
WO2006022536A1 (en) New medical use of the meldonium
WO2019211483A1 (en) A composition for reduction of scar formation
EP1842858A2 (en) Methods and compositions for treating oral and esophageal lesions
MXPA97006182A (es) Uso de acido hialuronico para el tratamiento de cistitis intersticial
AU2007240204A1 (en) Methods and compositions for treating oral and esophageal lesions

Legal Events

Date Code Title Description
FZDE Dead

Effective date: 20160610